KORU Medical names Eric Schiller as chief technology officer

KORU Medical Systems, Inc. (NASDAQ: KRMD) appointed Eric Schiller as Chief Technology Officer, effective December 29, 2025, according to a company announcement.

Schiller brings more than 25 years of experience in research and development, device engineering, and product lifecycle management. He will lead the company's product development and innovation pipeline while shaping long-term technology strategy.

Most recently, Schiller served as Global Head of Device Development Portfolio at Sanofi, where he led a global team and oversaw more than 80 pipeline assets across multiple therapeutic areas. Prior to Sanofi, he spent over a decade at Bristol-Myers Squibb and Celgene in device development and product strategy roles, supporting launches for immunology and hematology therapies requiring complex delivery systems.

His earlier career included engineering positions at Becton Dickinson and Saint-Gobain, focusing on syringe platform development and process improvement initiatives. Schiller holds an MBA from Seton Hall University and a Bachelor of Science in Mechanical Engineering from the New Jersey Institute of Technology. He is an inventor on more than a dozen U.S. patents related to injection devices and drug-delivery components.

"Eric will bring expertise in senior technology leadership that aligns product innovation with the rapidly evolving needs of the market," said Linda Tharby, CEO of KORU Medical Systems.

KORU Medical develops and manufactures subcutaneous infusion solutions, including the Freedom Syringe Infusion System, which received its first FDA clearance in 1994. The company serves patients for self-administration and healthcare professionals in ambulatory infusion centers.

You May Also Be Interested In

• Humana names Dr. Shantanu Nundy as chief medical officer
• Ingredion names Diego Reynoso as CFO, effective October 2026
• Jack in the Box names former Taco Bell executive as president